Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus epidermidis | 3 | 2016 | 16 | 1.490 |
Why?
|
| Biofilms | 5 | 2016 | 202 | 1.430 |
Why?
|
| Catheter-Related Infections | 3 | 2014 | 55 | 1.340 |
Why?
|
| Neonatal Abstinence Syndrome | 4 | 2023 | 25 | 1.320 |
Why?
|
| Staphylococcal Infections | 3 | 2016 | 302 | 1.160 |
Why?
|
| Informatics | 1 | 2023 | 9 | 0.900 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 53 | 0.830 |
Why?
|
| Parturition | 2 | 2023 | 53 | 0.810 |
Why?
|
| Rural Population | 2 | 2023 | 598 | 0.780 |
Why?
|
| Fetal Blood | 1 | 2020 | 67 | 0.760 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 128 | 0.730 |
Why?
|
| Overweight | 1 | 2022 | 240 | 0.730 |
Why?
|
| Placenta | 1 | 2020 | 136 | 0.690 |
Why?
|
| Infectious Disease Medicine | 1 | 2018 | 5 | 0.690 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 363 | 0.690 |
Why?
|
| Catheters, Indwelling | 2 | 2016 | 68 | 0.680 |
Why?
|
| Health Care Surveys | 1 | 2019 | 195 | 0.670 |
Why?
|
| Clinical Protocols | 1 | 2019 | 122 | 0.670 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 36 | 0.670 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2019 | 43 | 0.660 |
Why?
|
| Asthma | 1 | 2022 | 293 | 0.660 |
Why?
|
| Career Choice | 1 | 2018 | 114 | 0.620 |
Why?
|
| Cytokines | 2 | 2019 | 677 | 0.610 |
Why?
|
| Equipment Contamination | 1 | 2016 | 26 | 0.580 |
Why?
|
| Interleukin-10 | 1 | 2016 | 106 | 0.560 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2014 | 20 | 0.550 |
Why?
|
| Pediatrics | 1 | 2018 | 323 | 0.520 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2014 | 28 | 0.490 |
Why?
|
| Child | 9 | 2023 | 7368 | 0.470 |
Why?
|
| Bacterial Infections | 1 | 2014 | 105 | 0.460 |
Why?
|
| Trans-Activators | 1 | 2013 | 147 | 0.440 |
Why?
|
| Meningoencephalitis | 1 | 2012 | 8 | 0.440 |
Why?
|
| Brain | 3 | 2016 | 1392 | 0.400 |
Why?
|
| Medical Records | 2 | 2022 | 92 | 0.380 |
Why?
|
| Postoperative Complications | 2 | 2014 | 1035 | 0.370 |
Why?
|
| United States | 7 | 2023 | 5208 | 0.370 |
Why?
|
| Humans | 20 | 2023 | 54391 | 0.360 |
Why?
|
| Infant, Newborn | 7 | 2023 | 2923 | 0.360 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 456 | 0.350 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 500 | 0.340 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 1696 | 0.320 |
Why?
|
| Data Collection | 2 | 2023 | 320 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 2001 | 0.250 |
Why?
|
| Hydrocephalus | 2 | 2014 | 42 | 0.240 |
Why?
|
| Mice | 5 | 2016 | 6428 | 0.240 |
Why?
|
| Obesity | 2 | 2022 | 1203 | 0.230 |
Why?
|
| Pharyngitis | 1 | 2022 | 17 | 0.220 |
Why?
|
| Male | 8 | 2020 | 27347 | 0.220 |
Why?
|
| Adolescent | 4 | 2022 | 6900 | 0.210 |
Why?
|
| Vitamins | 1 | 2022 | 72 | 0.210 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 58 | 0.210 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2023 | 179 | 0.210 |
Why?
|
| Inflammation | 3 | 2016 | 678 | 0.210 |
Why?
|
| Vitamin D | 1 | 2022 | 101 | 0.210 |
Why?
|
| Capacity Building | 1 | 2021 | 19 | 0.200 |
Why?
|
| Indians, North American | 1 | 2021 | 38 | 0.200 |
Why?
|
| Child Welfare | 1 | 2021 | 73 | 0.200 |
Why?
|
| Solubility | 1 | 2020 | 75 | 0.190 |
Why?
|
| Perinatal Care | 1 | 2020 | 26 | 0.190 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 60 | 0.190 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 51 | 0.190 |
Why?
|
| Pandemics | 2 | 2022 | 594 | 0.180 |
Why?
|
| Lipids | 1 | 2020 | 178 | 0.180 |
Why?
|
| Nutritional Status | 1 | 2020 | 158 | 0.180 |
Why?
|
| Body Mass Index | 1 | 2022 | 712 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 594 | 0.170 |
Why?
|
| Female | 7 | 2023 | 28471 | 0.170 |
Why?
|
| Animals | 5 | 2016 | 14409 | 0.170 |
Why?
|
| Primary Health Care | 1 | 2022 | 398 | 0.170 |
Why?
|
| Medical Errors | 1 | 2019 | 34 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 367 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 491 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 159 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 232 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2018 | 100 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 269 | 0.150 |
Why?
|
| Infant | 3 | 2023 | 3829 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1647 | 0.150 |
Why?
|
| Pregnancy | 2 | 2023 | 2639 | 0.150 |
Why?
|
| Students, Medical | 1 | 2018 | 178 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2016 | 927 | 0.140 |
Why?
|
| Retrospective Studies | 4 | 2022 | 6459 | 0.130 |
Why?
|
| Research Design | 3 | 2022 | 375 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 63 | 0.120 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 4 | 0.120 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 8 | 0.120 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 25 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2022 | 4158 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 61 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 69 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 250 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 40 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2010 | 50 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 106 | 0.090 |
Why?
|
| Chlamydia muridarum | 1 | 2010 | 53 | 0.090 |
Why?
|
| Monocytes | 1 | 2010 | 156 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2010 | 195 | 0.090 |
Why?
|
| Young Adult | 1 | 2019 | 4318 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 825 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 1504 | 0.070 |
Why?
|
| Arkansas | 2 | 2022 | 2100 | 0.070 |
Why?
|
| Streptococcus pyogenes | 1 | 2022 | 18 | 0.060 |
Why?
|
| Narcotics | 1 | 2023 | 105 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 50 | 0.050 |
Why?
|
| Eating | 1 | 2023 | 163 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 149 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 124 | 0.050 |
Why?
|
| Sleep | 1 | 2023 | 188 | 0.050 |
Why?
|
| Safety | 1 | 2021 | 92 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 1082 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 693 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 64 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1083 | 0.040 |
Why?
|
| Adult | 2 | 2022 | 14207 | 0.030 |
Why?
|
| Time Factors | 1 | 2023 | 3210 | 0.030 |
Why?
|
| Vaginitis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2010 | 26 | 0.020 |
Why?
|
| Interleukins | 1 | 2010 | 39 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 51 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 100 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5612 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 2010 | 119 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 374 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1203 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3937 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1063 | 0.020 |
Why?
|